|
Zmitrukevich A.S., Kopat A.E.
Modern scientific conceptions about taurine
|
№3 / 2020
|
|
Minyakova E.V., Zhapueva M.H., Grishina I.S., Kokorin V.A.
Case report of the patient with erythrocytosis and secondary arterial hypertension associated with hormone replacement therapy for gender reassignment
|
№3 / 2020
|
|
Izmozherova N.V., Popov A.A., Bakhtin V.M.
Hypertension outpatients’ therapy by angiotensin-converting enzyme inhibitors and angiotensin-II first type receptors blockers
|
№3 / 2020
|
|
Chulkov V.S., Lenetz E.A.
Sartans: from treatment of hypertension to management of cardiovascular risk
|
№7 / 2019
|
|
Malimon V.V., Kokorin V.A., Gordeev I.G.
Treatment and diagnostical approaches to curation of patients with acute arterial blood pressure elevation
|
№6 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A.
Cystatin C as a marker of chronic kidney desease
|
№4 / 2019
|
|
Khadzegova A.B., Sinitsyna I.A., Borschevskaya M.V.
Influence of left ventricle remodeling on the rates of functional state in patients with arterial hypertension
|
№4 / 2019
|
|
Redko Yu.P., Gladkikh N.N., Yagoda A.V., Chumakov P.I.
Arterial hypertension in case of the presence of addictive renal arteries: the role of renin and aldosterone
|
№2 / 2019
|
|
Kazakova I.A., Ievlev Y.N.
Electrophoretic mobility of erythrocytes in patients with chronic renal disease of 5th dialysis stage with different level of arterial pressure
|
№2 / 2019
|
|
Vyalkina N.A., Klyashev S.M., Vyalkina Y.A., Mezhonov E.M., Klyasheva Y.M.
Peculiarities of the daily profile of arterial pressure and its impact on the outcomes of patients with chronic kidneys disease, receiving program hemodialysis
|
№2 / 2019
|
|
Ievlev Y.N., Kazakova I.A.
Sexual function as a quality of life parameter of patients with chronic kidney disease (stage 5) and arterial hypertension
|
№2 / 2019
|
Русский
